The proposed EU transparency directive - will it support the evolving pricing & reimbursement landscape for pharma?
This article was originally published in SRA
Executive Summary
Maarten Meulenbelt discusses the European Commission's long-awaited draft of a new transparency directive and considers its potential impact on industry and regulators.